Palm Beach Research center
West Palm Beach, Florida 33409-3401
4 studies enrolling now · 111 studies all time
What they study most
Actinic Keratosis, Alopecia, Alzheimer Disease, Analgesia, Arthritis, Arthritis, Rheumatoid, Asthma, Back Pain Lower Back Chronic, COVID-19, Chikungunya Virus, Chronic Idiopathic Constipation, Chronic Low Back Pain
Studies at this site
- A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee — Recruiting now
- AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea — Recruiting now
- DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea. — Recruiting now
- Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide — Running, not enrolling
- A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight — Completed
- RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA — Completed
- RCT, Blinded, 2-Arm Efficacy Study of IP and Placebo in Patients With Chronic Pain Related to Osteoarthritis of the Knee — Running, not enrolling
- Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection — Stopped early
- A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide — Starting soon
- Efficacy and Safety of NVX-CoV2705 — Running, not enrolling
- A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19 — Completed
- A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age — Running, not enrolling
- Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities — Completed
- Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 Injections for Pain Associated With Osteoarthritis of the Knee — Completed
- A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine — Running, not enrolling
- A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19 — Stopped early
- A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3) — Running, not enrolling
- Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2) — Running, not enrolling
- A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older — Completed
- A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated With Menopause — Completed
- KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers — Completed
- Continuation Protocol for Obstructive Sleep Apnea (OSA) — Enrolling by invitation
- Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea — Completed
- A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder — Completed
- LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs) — Completed
- A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults — Completed
- A Phase III Trial of e-TNS for the Acute Treatment of Migraine — Completed
- A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine) — Completed
- A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine — Completed
- A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 — Completed
- MSB11022 in Moderate to Severe Chronic Plaque Psoriasis — Completed
- A Safety, Tolerability, and Efficacy Study of IBI314 in Ambulatory Patients With COVID-19 — Stopped early
- To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia — Completed
- A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine — Completed
- Evaluate the Use of the Foundation Pain Index and the Nutritional Supplement BioPlete™ in Adults With Chronic Pain — Completed
- Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis — Completed
- To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin Lesions — Completed
- Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain — Completed
- A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis — Completed
- A Phase 2 Study to Evaluate Immune Responses of FluMist® — Completed
- A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) — Stopped early
- The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis — Completed
- A Study of Tanezumab in Adults With Chronic Low Back Pain — Completed
- Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine — Completed
- Open Label Extension Study of PREOS — Completed
- TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis — Completed
- Tanezumab In Osteoarthritis Of The Hip Or Knee — Stopped early
- Tanezumab In Osteoarthritis Of The Knee (2) — Completed
- Extension Study Of Tanezumab In Osteoarthritis — Stopped early
- Long Term Safety Study of Tanezumab in Chronic Low Back Pain — Stopped early